Information Provided By:
Fly News Breaks for September 16, 2016
Sep 16, 2016 | 06:28 EDT
Cowen analyst Bitu Baral downgraded Raptor Pharmaceuticals (RPTP) to Market Perform saying the acquisition by Horizon Pharma (HZNP) for $9 per share in cash is expected to close in Q4 and he does not expect any other bids.
News For RPTP From the Last 2 Days
There are no results for your query RPTP